cAMP response element-binding protein mediates immune-evasion of KRAS-mutant lung adenocarcinoma

G. Giotopoulou (Munich, Germany), G. Ntaliarda (Patras, Greece), A. ?arazioti (Patras, Greece), I. Lilis (Patras, Greece), N. Spiropoulou (Patras, Greece), F. Kalogianni (Patras, Greece), E. Tourkochristou (Patras, Greece), I. Giopanou (Patras, Greece), M. Spella (Patras, Greece), M. Iliopoulou (Patras, Greece), A. Korfiati (Hampshire, United Kingdom), K. Theofilatos (Hampshire, United Kingdom), S. Mavroudi (Hampshire, United Kingdom), T. Mantamadiotis (Melbourne, Australia), T. Goldmann (Borstel, Germany), S. Marwitz (Borstel, Germany), G. Stathopoulos (Munich, Germany)

Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Session: Biology of lung cancer: preclinical and translational research
Session type: E-poster
Number: 1116

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Giotopoulou (Munich, Germany), G. Ntaliarda (Patras, Greece), A. ?arazioti (Patras, Greece), I. Lilis (Patras, Greece), N. Spiropoulou (Patras, Greece), F. Kalogianni (Patras, Greece), E. Tourkochristou (Patras, Greece), I. Giopanou (Patras, Greece), M. Spella (Patras, Greece), M. Iliopoulou (Patras, Greece), A. Korfiati (Hampshire, United Kingdom), K. Theofilatos (Hampshire, United Kingdom), S. Mavroudi (Hampshire, United Kingdom), T. Mantamadiotis (Melbourne, Australia), T. Goldmann (Borstel, Germany), S. Marwitz (Borstel, Germany), G. Stathopoulos (Munich, Germany). cAMP response element-binding protein mediates immune-evasion of KRAS-mutant lung adenocarcinoma. 1116

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
YI403 - cAMP response element-binding protein mediates immune-evasion of KRASmutant lung adenocarcinoma
Source: ERS Lung Science Conference 2021
Year: 2021

LSC - 2021 - cAMP response element-binding protein mediates immune-evasion of KRAS-mutant lung adenocarcinoma
Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer
Year: 2021



CREB signaling in KRAS-driven lung adenocarcinoma
Source: ERS Lung Science Conference 2017
Year: 2017

LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma
Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome
Year: 2017

Caspase recruitment domain containing protein 9 suppresses non-small cell lung cancer proliferation and invasion via inhibiting MAPK/p38 pathway
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020

MicroRNA-101 inhibits lung cancer growth and invasion through regulation of EZH2
Source: Annual Congress 2010 - Pathology of lung cancer
Year: 2010

MEK5 promotes lung adenocarcinoma
Source: Eur Respir J, 53 (2) 1801327; 10.1183/13993003.01327-2018
Year: 2019



miRNA-17 and -144 regulate cAMP-responsive element binding protein (CREB1) signaling in murine ovalbumin-induced asthma and in human bronchial epithelial cells
Source: Annual Congress 2012 - Mechanistic studies in airway cell biology
Year: 2012

EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020

Salinomycin suppresses TGF-ß1-induced EMT by down-regulating MMP-2,9 via AMPK-SIRT1 pathway in a non-small cell lung cancer
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017

GSK-3 inhibition suppresses lung cancer cell survival, metastasis and proliferation through down-regulation the phosphorylation sites of CAP1
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017

Inhibition of hypoxia-induced phenotype alterations through epithelial-mesenchymal transition (EMT) in lung cancer by gene modulation of phosphorylation sites in tumor suppressor PTEN
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011

Functional expressions of EGFP/LKB1 and its kinase domain induced apoptosis and enhanced chemosensitivity in lung cancer cell lines
Source: Eur Respir J 2004; 24: Suppl. 48, 5s
Year: 2004

CDCA promotes non-small-cell lung cancer (NSCLC) migration by regulating Akt/Erk1/2 signaling pathways
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019

The upregulation of Osteopontin mediates acquired resistance to EGFR-TKI in NSCLC through Integrin/FAK signaling
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020

KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020

Differential role of EPAC and PKA in the transduction of cAMP-mediated inhibition of human lung fibroblast proliferation and collagen synthesis
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009


Activation of NRF2 is responsible for the overexpression of peroxiredoxin and sulphiredoxin in human lung cancer
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009

Bile acid receptor accelerates to the lung cancer process induced by lung fibroblast-tumor cells interaction, with high activation of phosphorylated STAT3 and alteration of cytokine secretion
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017

Adenovirus-mediated E2F-1 gene transfer in nonsmall-cell lung cancer induces cell growth arrest and apoptosis
Source: Eur Respir J 2002; 20: 703-709
Year: 2002